Je. Piletz et al., PLATELET-I-1 IMIDAZOLINE BINDING-SITES ARE DECREASED BY 2 DISSIMILAR ANTIDEPRESSANT AGENTS IN DEPRESSED-PATIENTS, Journal of Psychiatric Research, 30(3), 1996, pp. 169-184
Previous studies have indicated that there may be a dysregulation of a
lpha(2)-adrenoceptors and imidazoline receptors in depression. This st
udy compares the effects of chronic antidepressant treatment with a se
rotonin reuptake inhibitor (fluoxetine) versus a noradrenaline reuptak
e inhibitor (desipramine) on the binding parameters of the platelet im
idazoline binding site (subtype I-1) and of the platelet alpha(2)-adre
noceptor in depressed patients. After 6 weeks of treatment with either
antidepressant, platelet I-1 binding sites became normalized (i.e. do
wnregulated). A negative correlation was obtained between plasma epine
phrine concentrations and platelet alpha(2)-adrenoceptor B-max values
within the samples, but no correlation was obtained between any plasma
catecholamine and a platelet I-1 binding parameter. An additional fin
ding was the increased affinity of alpha(2)-adrenoceptors for p(125)I-
clonidine in untreated depressed patients compared to healthy subjects
. Because of the density of platelet I-1 binding sites was downregulat
ed by both of the antidepressants, we postulate that a decrease in pla
telet I-1 binding site density may be related to an improved state fro
m depression that these antidepressants produce. Copyright (C) 1996 El
sevier Science Ltd.